The legacy of Viagra and its creator , copyright, presents a complex picture for cautious investors. While the revolutionary drug initially generated enormous earnings, its exclusivity has lapsed , leading to competing versions flooding the landscape . This reduction in value presents a real obstacle for copyright and any fund considering a heavy h